Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to monitor clinical status, adverse events and laboratory
investigations and assess relative safety and tolerance of Atorvastatin formulations under
fasting conditions.